Knowledge, attitude and practice of hemovigilance among health care professionals and hemovigilance study in a tertiary care hospital
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250312Keywords:
Febrile-non haemolytic reactions, Health care professional, Transfusion associated circulatory overload, Transfusion associated dyspnoea, Transfusion reaction reporting form, Transfusion related acute lung injuryAbstract
Background: Clinical staff’s wisely varying transfusion techniques result in the misuse of blood products and endanger patient safety. Hemovigilance seeks to improve the quality and safety of blood transfusions. This study aimed in order to find out the knowledge, attitude and practice of hemovigilance among HCP’s and to know the incidence and prevalence of ATR in a tertiary care hospital.
Methods: An observational study of 120 HCP’s is planned to be conducted at Hospital. Pre-validated KAP questionnaire were issued. The frequency of ATR was recorded in TRRF form. At end of the study through collected data, we will subject it to statistical analysis.
Results: From the view of 120 HCP, only 40 % had knowledge on the hemovigilance, and a whopping 74% is not practicing Hemovigilance safety measures. But we are happy to see that 71% have a positive attitude. Out of 40 transfusion reactions, a majority of patients had encountered FNHTR and allergic reaction, that is of 30%. Followed by delayed haemolytic reaction, TACO, TAD of 10%. And 5% did get hypotensive reaction and TRALI. Coming to type of blood component administered PRBC (60%), whole blood and FFP 20% each were seen. Out of 40 ,30 female patients (75%) and 10 (25%) reported ATR.
Conclusions: Even though The HCP have positive attitude towards blood safety, the knowledge and practice of HCP is proven to be poor. The frequency of ATR showed although they are less severe if no strict monitory actions are not taken, they may turn life threatening.
Metrics
References
Lamba DS, Sachdev S, Hans R, Dhawan HK, Sharma RR, Marwaha N. Review of blood donor deferral with emphasis on donor and patient safety. Transfusion Clinique et Biologique. 2023;30(1):56-62. DOI: https://doi.org/10.1016/j.tracli.2022.07.002
Marwaha N, Singh S, Bisht A. Setting up haemovigilance from the very first step. The Indian perspective. ISBT Sci Series. 2014;9(1):178-83. DOI: https://doi.org/10.1111/voxs.12084
Kleinman S, Silvergleid AJ, Tirnauer JS. Patient education: Blood donation and transfusion (Beyond the Basics).
NACO. Assessment of blood banks in India, 2016. New Delhi: National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India. Available at: http://www.naco.gov.in. Accessed 01 May 2007.
National AIDS Control Organisation. Ministry of Health and Family Welfare Government of India. 10 An Action Plan for Blood Safety 2003. Available at: http://www.naco.gov.in. Accessed 01 May 2007.
Khobragade RS, Paranjape SG, Gadhade JB, Premchand A. Hemovigilance: a momentous step to blood safety. Int J Basic Clin Pharmacol. 2022;11(3):267. DOI: https://doi.org/10.18203/2319-2003.ijbcp20221043
Boparai JK, Singh S. Hemovigilance: A new beginning in India. Int J Appl Basic Med Res. 2015;5(3):200-2. DOI: https://doi.org/10.4103/2229-516X.165379
McClosky ME, Cimino Brown D, Weinstein NM, Chappini N, Taney MT, et al. Prevalence of naturally occurring non‐AB blood type incompatibilities in cats and influence of cross match on transfusion outcomes. J Veterinary Int Medi. 2018;32(6):1934-42. DOI: https://doi.org/10.1111/jvim.15334
Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, et al. International validation of harmonized definitions for complications of blood donations. Transfusion. 2018;58(11):2589-95. DOI: https://doi.org/10.1111/trf.14948
Aubron C, Aries P, Le Niger C, Sparrow RL, Ozier Y. How clinicians can minimize transfusion-related adverse events? Transfusion Clinique et Biologique. 2018;25(4):257-61. DOI: https://doi.org/10.1016/j.tracli.2018.08.158
Garraud O, Cognasse F, Laradi S, Hamzeh-Cognasse H, et al. How to mitigate the risk of inducing transfusion-associated adverse reactions? Transf Clin Biolog. 2018;25(4):262-8. DOI: https://doi.org/10.1016/j.tracli.2018.07.006
Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, et al. Impact of red blood cell antigen matching on Allo-immunization and transfusion complications in patients with sickle cell disease: a systematic review. Transf Medi Revi. 2019;33(1):12-23. DOI: https://doi.org/10.1016/j.tmrv.2018.07.003
Strasser E. The new hemotherapy guideline. Der Unfallchirurg. 201;121:423-8. DOI: https://doi.org/10.1007/s00113-018-0489-4
Jasinski S, Glasser CL. Catastrophic delayed hemolytic transfusion reaction in a patient with sickle cell disease without alloantibodies: Case report and review of literature. J Paediat Haematol/Oncol. 2019;41(8):624-6. DOI: https://doi.org/10.1097/MPH.0000000000001307
Erony SM, Marshall CE, Gehrie EA, Boyd JS, Ness PM, et al. The epidemiology of bacterial culture-positive and septic transfusion reactions at a large tertiary academic centre: 2009 to 2016. Transfusion. 201;58(8):1933-9. DOI: https://doi.org/10.1111/trf.14789
Py JY, Cabezon B, Sapey T, Jutant T. Unacknowledged adverse transfusion reactions: Are they a mine to dig? Transf Clin Biolo. 2018;25(1):63-72. DOI: https://doi.org/10.1016/j.tracli.2017.06.016
Bryan S. Hemolytic transfusion reaction: safeguards for practice. J Peri Anesth Nurs. 2002;17(6):399-403. DOI: https://doi.org/10.1053/jpan.2002.36782
Panch SR, Montemayor C. Hemolytic transfusion reactions. Rossi's Prin Transfu Medi. 2022:543-52. DOI: https://doi.org/10.1002/9781119719809.ch47
Behnammoghadam M, Fazelniya Z, Bayat AH, Jahanfar A, et al. Effect of hemovigilance education on nursing students’ knowledge: the application of a conceptual map. Fronti Nur. 2022;9(3):295-301. DOI: https://doi.org/10.2478/fon-2022-0037
Vuk T, Politis C, de Angelis V, Lozano M, Haddad A, et al. Education in transfusion medicine, Part III–The importance of haemovigilance education. Transf Clin Biolog. 2023;30(2):294-302. DOI: https://doi.org/10.1016/j.tracli.2023.02.002
Shivgunde P, Bhojwani D, Bhojwani K. Knowledge and attitude on hemovigilance program. Int J Basi Clin Pharmacol. 2021;7(5):986. DOI: https://doi.org/10.18203/2319-2003.ijbcp20181647
Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Phys. 2011;83(6):719-24.
Bhattacharya P, Marwaha N, Dhawan HK, Roy P, Sharma RR. Transfusion-related adverse events at the tertiary care centre in North India: An institutional hemovigilance effort. Asian J Transfu Sci. 2011;5(2):164-70. DOI: https://doi.org/10.4103/0973-6247.83245
Kumar P, Thapliyal R, Coshic P, Chatterjee K. Retrospective evalua tion of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance. Asian J Transf Sci. 2013;7(2):109-15. DOI: https://doi.org/10.4103/0973-6247.115564
HimaBindu K, Sudha J. Knowledge, Attitude, Perception of Hemovigilance among Post-Graduates in Tertiary Care Hospital, King George Hospital, Visakhapatnam, Andhra pradesh. Transfusion. 2020;24:20.